Every recall we track for Esperion — 2 in all — plus the complaints and injury reports the public filed about them.
Esperion recalls NEXLIZET 180/10 mg tablets due to failed dissolution testing at 0 months. This may affect medication effectiveness. Check NDC 72426-818-03 and lot numbers for affected products.
Esperion recalls Nexlizet (bempedoic acid and ezetimibe) tablets due to failed dissolution specifications at 12-month stability. Affected lots manufactured in 2024 with expiration dates up to 2025.
